178 related articles for article (PubMed ID: 35482948)
1. Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437.
Gagestein B; Stevens AF; Fazio D; Florea BI; van der Wel T; Bakker AT; Fezza F; Dulk HD; Overkleeft HS; Maccarrone M; van der Stelt M
ACS Chem Biol; 2022 May; 17(5):1174-1183. PubMed ID: 35482948
[TBL] [Abstract][Full Text] [Related]
2. The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors.
Reynoso-Moreno I; Chicca A; Flores-Soto ME; Viveros-Paredes JM; Gertsch J
Front Mol Neurosci; 2018; 11():180. PubMed ID: 29910713
[TBL] [Abstract][Full Text] [Related]
3. Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain.
Khasabova IA; Holman M; Morse T; Burlakova N; Coicou L; Harding-Rose C; Simone DA; Seybold VS
Neurobiol Dis; 2013 Oct; 58():19-28. PubMed ID: 23644187
[TBL] [Abstract][Full Text] [Related]
4. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
Jacobsson SO; Fowler CJ
Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
[TBL] [Abstract][Full Text] [Related]
5. Evidence for bidirectional endocannabinoid transport across cell membranes.
Chicca A; Marazzi J; Nicolussi S; Gertsch J
J Biol Chem; 2012 Oct; 287(41):34660-82. PubMed ID: 22879589
[TBL] [Abstract][Full Text] [Related]
6. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
[TBL] [Abstract][Full Text] [Related]
7. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for the existence of a specific process for the membrane transport of anandamide.
Ligresti A; Morera E; Van Der Stelt M; Monory K; Lutz B; Ortar G; Di Marzo V
Biochem J; 2004 May; 380(Pt 1):265-72. PubMed ID: 14969584
[TBL] [Abstract][Full Text] [Related]
9. Anandamide transport: a critical review.
Glaser ST; Kaczocha M; Deutsch DG
Life Sci; 2005 Aug; 77(14):1584-604. PubMed ID: 15979096
[TBL] [Abstract][Full Text] [Related]
10. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
[TBL] [Abstract][Full Text] [Related]
11. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.
Bari M; Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
J Biol Chem; 2005 Apr; 280(13):12212-20. PubMed ID: 15657045
[TBL] [Abstract][Full Text] [Related]
12. Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake.
Chicca A; Nicolussi S; Bartholomäus R; Blunder M; Aparisi Rey A; Petrucci V; Reynoso-Moreno IDC; Viveros-Paredes JM; Dalghi Gens M; Lutz B; Schiöth HB; Soeberdt M; Abels C; Charles RP; Altmann KH; Gertsch J
Proc Natl Acad Sci U S A; 2017 Jun; 114(25):E5006-E5015. PubMed ID: 28584105
[TBL] [Abstract][Full Text] [Related]
13. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis.
Szilagyi JT; Composto-Wahler GM; Joseph LB; Wang B; Rosen T; Laskin JD; Aleksunes LM
Pharmacol Res; 2019 Mar; 141():331-342. PubMed ID: 30610963
[TBL] [Abstract][Full Text] [Related]
14. The endogenous cannabinoid, anandamide, inhibits dopamine transporter function by a receptor-independent mechanism.
Oz M; Jaligam V; Galadari S; Petroianu G; Shuba YM; Shippenberg TS
J Neurochem; 2010 Mar; 112(6):1454-64. PubMed ID: 20050977
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase.
Maccarrone M; Di Rienzo M; Battista N; Gasperi V; Guerrieri P; Rossi A; Finazzi-Agrò A
J Biol Chem; 2003 Sep; 278(36):33896-903. PubMed ID: 12815050
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
17. A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons.
Price TJ; Patwardhan AM; Flores CM; Hargreaves KM
Neuropharmacology; 2005 Jul; 49(1):25-39. PubMed ID: 15992578
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the endocannabinoid system in human neuronal cells and proteomic analysis of anandamide-induced apoptosis.
Pasquariello N; Catanzaro G; Marzano V; Amadio D; Barcaroli D; Oddi S; Federici G; Urbani A; Finazzi Agrò A; Maccarrone M
J Biol Chem; 2009 Oct; 284(43):29413-26. PubMed ID: 19690173
[TBL] [Abstract][Full Text] [Related]
19. Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid.
Hillard CJ; Campbell WB
J Lipid Res; 1997 Dec; 38(12):2383-98. PubMed ID: 9458263
[TBL] [Abstract][Full Text] [Related]
20. Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling.
Soliman E; Van Dross R
Mol Carcinog; 2016 Nov; 55(11):1807-1821. PubMed ID: 26513129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
